With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...

Additionally, US exchanges like the New York Stock Exchange and Nasdaq are among the ... Number of Hedge Fund Holders: 80 Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets ...

Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...

Community Bank N.A. cut its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 26.5% in the fourth quarter, according to its ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

NEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Tuesday reported fourth-quarter profit of $410 million. The New York-based company said it had net income of 7 cents per share. Earnings, adjusted ...